Hok Hei Tam

Opinion Author

Hok Hei Tam, Ph.D., is the co-founder and chief technology officer at Montai Therapeutics. He is also a senior principal at Flagship Pioneering, where he is part of a team of entrepreneurial scientists that develop the science, IP, and business strategy that form the foundation of Flagship’s breakthrough startups.

Drug development powered by artificial intelligence is countering incentives from the Inflation Reduction Act and making small molecules more attractive in the complex inflammatory & immunology disease space.